About Us
Our Mission
NemaGen Discoveries’ mission is to advance therapies for patients suffering from mast cell-related diseases and chronic inflammation.
Our Technology
NemaGen's technologies were developed by studying the body's natural ability to restrict inflammation in the context of parasitic infections. This unique approach has revealed new and exciting therapeutic targets and allowed us to pioneered the development of first-in-class therapies with novel mechanisms of action.
Our Team
NemaGen was founded by Mark C. Siracusa Ph.D. an expert in the fields of parasitology and immunology. Dr. Siracusa has partnered with experts in the advancement of early phase biotech companies and has established, experienced, and results-driven team.
Our Partners
